Literature DB >> 8254048

Impairment of cardiac function and energetics in experimental renal failure.

A E Raine1, A M Seymour, A F Roberts, G K Radda, J G Ledingham.   

Abstract

Cardiac function and energetics in experimental renal failure in the rat (5/6 nephrectomy) have been investigated by means of an isolated perfused working heart preparation and an isometric Langendorff preparation using 31P nuclear magnetic resonance (31P NMR). 4 wk after nephrectomy cardiac output of isolated hearts perfused with Krebs-Henseleit buffer was significantly lower (P < 0.0001) at all levels of preload and afterload in the renal failure groups than in the pair-fed sham operated control group. In control hearts, cardiac output increased with increases in perfusate calcium from 0.73 to 5.61 mmol/liter whereas uremic hearts failed in high calcium perfusate. Collection of 31P NMR spectra from hearts of renal failure and control animals during 30 min normoxic Langendorff perfusion showed that basal phosphocreatine was reduced by 32% to 4.7 mumol/g wet wt (P < 0.01) and the phosphocreatine to ATP ratio was reduced by 32% (P < 0.01) in uremic hearts. During low flow ischemia, there was a substantial decrease in phosphocreatine in the uremic hearts and an accompanying marked increase in release of inosine into the coronary effluent (14.9 vs 6.1 microM, P < 0.01). We conclude that cardiac function is impaired in experimental renal failure, in association with abnormal cardiac energetics and increased susceptibility to ischemic damage. Disordered myocardial calcium utilization may contribute to these derangements.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254048      PMCID: PMC288497          DOI: 10.1172/JCI116916

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Effects of moderate uremia on cardiac contractile responses.

Authors:  J Scheuer; T Nivatpumin; T Yipintsoi
Journal:  Proc Soc Exp Biol Med       Date:  1975-11

2.  EDITORIAL: The case for a specific uraemic myocardopathy.

Authors:  D Prosser; V Parsons
Journal:  Nephron       Date:  1975       Impact factor: 2.847

3.  Changes in the myocardial creatine kinase isozyme profile with progression and regression of volume overload eccentric hypertrophy.

Authors:  M L Field; C Thompson; C Henderson; A M Seymour; G K Radda
Journal:  Biochem Soc Trans       Date:  1992-05       Impact factor: 5.407

4.  Cardiac work demands and left ventricular function in end-stage renal disease.

Authors:  J P Capelli; H Kasparian
Journal:  Ann Intern Med       Date:  1977-03       Impact factor: 25.391

5.  Increased cardiac contractility in acute uremia: interrelationships with hypertension.

Authors:  T Nivatpumin; T Yipintsoi; S Penpargkul; J Scheuer
Journal:  Am J Physiol       Date:  1975-08

Review 6.  Kinetic analysis of ATPase mechanisms.

Authors:  D R Trentham; J F Eccleston; C R Bagshaw
Journal:  Q Rev Biophys       Date:  1976-05       Impact factor: 5.318

7.  The effects of uremic compounds on cardiac function and metabolism.

Authors:  J Scheuer; W Stezoski
Journal:  J Mol Cell Cardiol       Date:  1973-06       Impact factor: 5.000

8.  Cytosolic phosphorylation potential.

Authors:  R L Veech; J W Lawson; N W Cornell; H A Krebs
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

9.  Uremic cardiomyopathy: studies on cardiac function in the guinea pig.

Authors:  F Kersting; H Brass; R Heintz
Journal:  Clin Nephrol       Date:  1978-09       Impact factor: 0.975

10.  Uremic cardiomyopathy--effect of hemodialysis on left ventricular function in end-stage renal failure.

Authors:  J Hung; P J Harris; R F Uren; D J Tiller; D T Kelly
Journal:  N Engl J Med       Date:  1980-03-06       Impact factor: 91.245

View more
  11 in total

Review 1.  Targeted metabolic imaging to improve the management of heart disease.

Authors:  Moritz Osterholt; Shiraj Sen; Vasken Dilsizian; Heinrich Taegtmeyer
Journal:  JACC Cardiovasc Imaging       Date:  2012-02

2.  Mitochondrial dysfunction in uremic cardiomyopathy.

Authors:  David Taylor; Sunil Bhandari; Anne-Marie L Seymour
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

3.  The effect of uraemia on the duration of arrhythmias in the context of cardioprotective ischaemic conditioning strategies.

Authors:  Kieran McCafferty; Conor J Byrne; Julius Kieswich; Martin Raftery; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  Heart Asia       Date:  2014-05-24

4.  Cardiac function and tolerance to ischemia-reperfusion injury in chronic kidney disease.

Authors:  James M Kuczmarski; Christopher R Martens; Shannon L Lennon-Edwards; David G Edwards
Journal:  Nephrol Dial Transplant       Date:  2013-10-22       Impact factor: 5.992

5.  The influence of folic acid-induced acute kidney injury on cardiac function and redox status in rats.

Authors:  Tomislav Nikolic; Dejan Petrovic; Stevan Matic; Tamara Nikolic Turnic; Jovana Jeremic; Katarina Radonjic; Ivan Srejovic; Vladimir Zivkovic; Stefani Bolevich; Sergey Bolevich; Vladimir Jakovljevic
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-27       Impact factor: 3.000

Review 6.  Cardiac metabolic remodelling in chronic kidney disease.

Authors:  Nikayla Patel; Muhammad Magdi Yaqoob; Dunja Aksentijevic
Journal:  Nat Rev Nephrol       Date:  2022-05-30       Impact factor: 42.439

7.  Renal failure induces telomere shortening in the rat heart.

Authors:  L S Wong; W A Windt; A J Roks; R P van Dokkum; R G Schoemaker; D de Zeeuw; R H Henning
Journal:  Neth Heart J       Date:  2009-05       Impact factor: 2.380

8.  Experimental models of renal disease and the cardiovascular system.

Authors:  Rebecca C Grossman
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

9.  Myocardial bioenergetic abnormalities in experimental uremia.

Authors:  Alistair Ms Chesser; Steven M Harwood; Martin J Raftery; Muhammad M Yaqoob
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-05-24

10.  Cardiac Troponin I and Amino-Terminal Pro B-Type Natriuretic Peptide in Dogs With Stable Chronic Kidney Disease.

Authors:  L Pelander; J Häggström; C J Ley; I Ljungvall
Journal:  J Vet Intern Med       Date:  2017-04-03       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.